Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.
Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.